NBC NEWS – The request will be now considered by the FDA, which will review the data and could grant emergency use authorization for the age group later this month. The FDA’s advisory group, called the Vaccines and Related Biological Products Advisory Committee, is scheduled to convene on June 15 to offer guidance on the pediatric doses. The FDA could clear doses for the age group within days of a favorable recommendation from the committee. The Centers for Disease Control and Prevention will still need to sign off on the doses, as the agency has done for all other age groups.
Worth Reading at NBC NEWS
